Using the electroretinogram to detect and monitor the retinal toxicity of anticonvulsants

Neurology

Volumn 55, Issue 3, 2000, Pages 333-334

  Miller, Neil R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; TIAGABINE; VIGABATRIN;

ADULT; ANTICONVULSANT THERAPY; CHILD; DRUG INDUCED DISEASE; EDITORIAL; ELECTRORETINOGRAPHY; EPILEPSY; EYE TOXICITY; HUMAN; INFANT; PATIENT MONITORING; PRIORITY JOURNAL; RETINA DISEASE; SEIZURE; VISUAL ACUITY; VISUAL FIELD DEFECT;

EID: 0033846799     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.3.333     Document Type: Editorial

References (7)

1. Severe persistent visual field constriction associated with vigabatrin
2. Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmic findings
3. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
4. Visual dysfunction in patients receiving vigabatrin. Clinical and electrophysiologic findings
5. Visual field defects associated with vigabatrin therapy
6. Visual function loss from vigabatrin: Effect of stopping the drug
7. Separating the retinal electrophysiologic effects of vigabatrin: Treatment versus field loss